Bradley Robert Hudson, LMFT Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 201 W Lakeway Rd Ste 902, Gillette, WY 82718 Phone: 307-209-4649 Fax: 307-381-0493 |
Kristina Marie Leslie, LMFT-170 Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 3907 Chippewa Ave, Gillette, WY 82718 Phone: 949-922-3043 Fax: 307-363-4807 |
Kyle D Tew, M.S. M.F.T. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-1000 |
Amy Himes, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-8051 Fax: 307-688-5008 |
News Archive
In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's exclusively sponsored and landmark Multicenter Automatic Defibrillator Implantation Trial – Cardiac Resynchronization Therapy (MADIT-CRT) study demonstrated significant and sustained survival benefit for the indicated population.
The average IQ of adults who were born very preterm (VP) or at a very low birth weight (VLBW) has been compared to adults born full term by researchers from the Department of Psychology at the University of Warwick.
Based on limited research, there's no strong evidence that selective serotonin-reuptake inhibitors (SSRIs) - the most widely used class of antidepressants - have an adverse impact on fertility, according to a paper in the Harvard Review of Psychiatry.
Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today a restructuring that includes a facility consolidation and other staff reductions designed to increase operational efficiency and drive annualized cost savings.
"Drug donations, reinvestment of profits in developing countries and a more flexible approach to intellectual property have all signaled a more collaborative approach from industry with the likes of GlaxoSmithKline, Sanofi, Johnson & Johnson and Merck all performing well in the 2012 Access to Medicine Initiative," Adam Robert Green, senior reporter with the Financial Times' "This is Africa," writes in the Royal African Society's "African Arguments" blog.
› Verified 3 days ago